Ami A. Shah

9.0k total citations
162 papers, 5.2k citations indexed

About

Ami A. Shah is a scholar working on Pathology and Forensic Medicine, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ami A. Shah has authored 162 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Pathology and Forensic Medicine, 47 papers in Epidemiology and 42 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ami A. Shah's work include Systemic Sclerosis and Related Diseases (88 papers), Inflammatory Myopathies and Dermatomyositis (42 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Ami A. Shah is often cited by papers focused on Systemic Sclerosis and Related Diseases (88 papers), Inflammatory Myopathies and Dermatomyositis (42 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Ami A. Shah collaborates with scholars based in United States, United Kingdom and Canada. Ami A. Shah's co-authors include Fredrick M. Wigley, Laura C. Cappelli, Clifton O. Bingham, Livia Casciola‐Rosen, Laura K. Hummers, Antony Rosen, Francesco Boin, Evan J. Lipson, Jarushka Naidoo and Julie R. Brahmer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Ami A. Shah

147 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ami A. Shah United States 40 2.2k 1.4k 1.3k 1.3k 901 162 5.2k
Mandana Nikpour Australia 36 2.3k 1.1× 253 0.2× 1.2k 1.0× 688 0.5× 1.5k 1.7× 207 4.4k
László Czirják Hungary 35 3.4k 1.6× 224 0.2× 1.2k 0.9× 1.1k 0.8× 1.4k 1.5× 165 4.8k
Aryeh Fischer United States 40 3.9k 1.8× 1.5k 1.0× 6.3k 5.0× 2.4k 1.8× 986 1.1× 117 10.0k
Pierre‐Yves Hatron France 42 2.1k 1.0× 213 0.1× 2.0k 1.6× 1.7k 1.3× 866 1.0× 142 5.7k
Roger Hesselstrand Sweden 30 1.9k 0.9× 175 0.1× 1.1k 0.9× 530 0.4× 672 0.7× 128 3.2k
Luca Arcaini Italy 49 4.2k 1.9× 2.3k 1.6× 431 0.3× 687 0.5× 1.3k 1.4× 223 8.7k
Marco Sebastiani Italy 34 1.8k 0.8× 208 0.1× 1.3k 1.0× 1.1k 0.9× 556 0.6× 158 3.9k
Jacques‐Eric Gottenberg France 46 1.0k 0.5× 732 0.5× 520 0.4× 719 0.6× 1.7k 1.9× 163 7.1k
Franco Franceschini Italy 37 1.2k 0.5× 234 0.2× 498 0.4× 1.2k 0.9× 1.3k 1.4× 210 4.6k
Nadera Sweiss United States 36 578 0.3× 286 0.2× 1.8k 1.4× 445 0.4× 728 0.8× 132 3.9k

Countries citing papers authored by Ami A. Shah

Since Specialization
Citations

This map shows the geographic impact of Ami A. Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami A. Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami A. Shah more than expected).

Fields of papers citing papers by Ami A. Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ami A. Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami A. Shah. The network helps show where Ami A. Shah may publish in the future.

Co-authorship network of co-authors of Ami A. Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Ami A. Shah. A scholar is included among the top collaborators of Ami A. Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ami A. Shah. Ami A. Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Holt, Sarah K., John L. Gore, Yaw A. Nyame, et al.. (2025). Association Between Rheumatoid Arthritis, Frailty Status, and Mortality in Older Adults with Bladder Cancer. Clinical Genitourinary Cancer. 23(4). 102369–102369.
3.
Pimentel, Mark, Walter Morales, Laura K. Hummers, et al.. (2025). Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis. Lara D. Veeken. 64(10). 5230–5237. 1 indexed citations
4.
Gray-Gaillard, Elise, Ami A. Shah, Clifton O. Bingham, et al.. (2025). Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis. Arthritis Research & Therapy. 27(1). 74–74. 2 indexed citations
5.
Wallwork, Rachel, Jonathan J. Kotzin, Laura C. Cappelli, et al.. (2024). Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Seminars in Arthritis and Rheumatism. 67. 152460–152460.
7.
Speiser, Lisa, Janis E. Blair, Ami A. Shah, et al.. (2023). A Case of Sustained Viral Shedding of Mpox With Ocular Involvement Resulting in Vision Loss. Open Forum Infectious Diseases. 11(1). ofad632–ofad632.
8.
Bass, Anne R., Noha Abdel‐Wahab, Pankti Reid, et al.. (2023). Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis. Annals of the Rheumatic Diseases. 82(7). 920–926. 39 indexed citations
9.
Fiorentino, David, Christopher A. Mecoli, Takeru Igusa, et al.. (2023). Association of Anti‐CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti–Transcriptional Intermediary Factor 1γ–Positive Dermatomyositis. Arthritis & Rheumatology. 75(7). 1238–1245. 21 indexed citations
10.
Mecoli, Christopher A., Brant Chee, Jemima Albayda, et al.. (2023). Diagnostic Yield of Computed Tomography for Cancer Detection in a Tertiary Referral Population of Idiopathic Inflammatory Myositis Patients. Arthritis Care & Research. 75(10). 2142–2150. 2 indexed citations
11.
Shah, Ami A., et al.. (2023). Allergic contact dermatitis of the eyelids: An interdisciplinary review. The Ocular Surface. 28. 124–130. 5 indexed citations
12.
Richardson, Carrie, Jamie Perin, Scott L. Zeger, et al.. (2022). Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosis. Lara D. Veeken. 62(11). 3636–3643. 7 indexed citations
13.
Mecoli, Christopher A., Takeru Igusa, Jemima Albayda, et al.. (2022). Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population. Arthritis & Rheumatology. 75(4). 620–629. 21 indexed citations
14.
Tiniakou, Eleni, Andrea Fava, Zsuzsanna H. McMahan, et al.. (2020). Definition of Naturally Processed Peptides Reveals Convergent Presentation of Autoantigenic Topoisomerase I Epitopes in Scleroderma. Arthritis & Rheumatology. 72(8). 1375–1384. 12 indexed citations
15.
Shin, Joseph, Rustam Bagirzadeh, Tyler J. Creamer, et al.. (2019). Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis. Science Translational Medicine. 11(497). 50 indexed citations
16.
Turan, Alparslan, Christine Y. Chang, Barak Cohen, et al.. (2019). Incidence, Severity, and Detection of Blood Pressure Perturbations after Abdominal Surgery. Anesthesiology. 130(4). 550–559. 94 indexed citations
17.
Wu, Zhenke, Livia Casciola‐Rosen, Ami A. Shah, Antony Rosen, & Scott L. Zeger. (2017). Estimating autoantibody signatures to detect autoimmune disease patient subsets. Biostatistics. 20(1). 30–47. 2 indexed citations
18.
Tedford, Ryan J., Benjamin W. Kelemen, Stephen C. Mathai, et al.. (2014). Abstract 11450: Comparison of Simplified (Single-beat) Estimates to Measured Right Ventricular End-Systolic Elastance and RV-Pulmonary Vascular Coupling in Patients With Pulmonary Hypertension. Circulation. 1 indexed citations
19.
Joseph, Christine, Erika Darrah, Ami A. Shah, et al.. (2013). Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer. Science. 343(6167). 152–157. 300 indexed citations
20.
Tedford, Ryan J., James O. Mudd, Reda E. Girgis, et al.. (2013). Right Ventricular Dysfunction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension. Circulation Heart Failure. 6(5). 953–963. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026